Group leader
Josep Manuel Llop
Principal investigators
Helena Colom
Núria Padullés
Clinical researchers
Pedro Alia
Maria Badia
Beatriz Candas
Encarna Garcia
Roser Juvany
Elisabet Leiva
Montserrat Miñarro
Ariadna Padulles
Pilar Perez
Raul Rigo
Josep M. Suñe
Josep Ramon Tico
Postdoctoral researchers
Ariadna Padro
Ramon Jodar
PhD students
Sara Cobo
Montserrat Colls
Ana Ferrer
Eugenia Santacana
Scientific production
23
PAPERS
53,292
TOTAL IF
3,135
MEAN IF
10 PUBLICATIONS IN FIRST QUARTILE
2 PUBLICATIONS IN FIRST DECILE
Highlights
- Alfon, J; Vidal, L; Gaba, L; Victoria, I; Gil, M; Laquente, B; Brunet, M; Colom, H; Ramis, J; Perez-Montoyo, H; Cortal, M; Gomez-Ferreria, M; Muñoz, P; Erazo, T; Lizcano, JM; Domenech, C; Gascon, P. Determination of recommended phase II dose of ABTL0812; a novel regulator of Akt/mTOR axis; by pharmacokinetic-pharmacodynamic modeling. Annals of Oncology 2016. DOI: 10.1093/annonc/mdw368
- Andreu, F; Colom, H; Elens, L; van Gelder, T; van Schaik, RH; Hesselink, DA; Bestard, O; Torras, J; Cruzado, JM; Grinyó, JM; Lloberas, N. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach. Clinical Pharmacokinetics 2016. DOI: 10.1007/s40262-016-0491-3
- Padulles, A; Colom, H; Bestard, O; Melilli, E; Sabe, N; Rigo, R; Niubo, J; Torras, J; Llado, L; Manito, N; Caldes, A; Cruzado, JM; Grinyo, JM; Lloberas, N. Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients. Antimicrobial Agents And Chemotherapy 2016. DOI: 10.1128/AAC.02130-15